Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Pediatric Vaccines market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Pediatric Vaccines market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Pediatric Vaccines market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Pediatric Vaccines products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Pediatric Vaccines products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Pediatric Vaccines market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Pediatric Vaccines development has been the leading industry trend of Pediatric Vaccines market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Pediatric Vaccines Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Diphtheria,Influenza,Hepatitis,Pneumococcal Diseases,Meningococcal Diseases,Others |
| By Application Outlook |
Newborn,Infant,Child,Dolescent |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
GlaxoSmithKline,Merck,Pfizer,Sanofi,AstraZeneca,Novartis,Takeda Pharmaceutical,Bavarian Nordic,Baxter,LG Life Sciences,Lupin,S K Chemicals,Mitsubishi Tanabe Pharma,Janssen,Shenzhen Kangtai Biological Products,Sinovac Biotech,Bharat Biotech,Crucell,Dynavax,Serum Institute of India |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- GlaxoSmithKline
- Merck
- Pfizer
- Sanofi
- AstraZeneca
- Novartis
- Takeda Pharmaceutical
- Bavarian Nordic
- Baxter
- LG Life Sciences
- Lupin
- S K Chemicals
- Mitsubishi Tanabe Pharma
- Janssen
- Shenzhen Kangtai Biological Products
- Sinovac Biotech
- Bharat Biotech
- Crucell
- Dynavax
- Serum Institute of India
Pediatric Vaccines Market, By Type
- Diphtheria
- Influenza
- Hepatitis
- Pneumococcal Diseases
- Meningococcal Diseases
- Others
Pediatric Vaccines Market, By Application
- Newborn
- Infant
- Child
- Dolescent
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Pediatric Vaccines Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Pediatric Vaccines Market Size Growth Rate by Product
1.4.2 Diphtheria
1.4.3 Influenza
1.4.4 Hepatitis
1.4.5 Pneumococcal Diseases
1.4.6 Meningococcal Diseases
1.4.7 Others
1.5 Market by End User
1.5.1 Global Pediatric Vaccines Market Size Growth Rate by End User
1.5.2 Newborn
1.5.3 Infant
1.5.4 Child
1.5.5 Dolescent
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pediatric Vaccines Market Size
2.1.1 Global Pediatric Vaccines Revenue 2014-2027
2.1.2 Global Pediatric Vaccines Sales 2014-2027
2.2 Pediatric Vaccines Growth Rate by Regions
2.2.1 Global Pediatric Vaccines Sales by Regions
2.2.2 Global Pediatric Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Pediatric Vaccines Sales by Manufacturers
3.1.1 Pediatric Vaccines Sales by Manufacturers
3.1.2 Pediatric Vaccines Sales Market Share by Manufacturers
3.1.3 Global Pediatric Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Pediatric Vaccines Revenue by Manufacturers
3.2.1 Pediatric Vaccines Revenue by Manufacturers (2014-2019)
3.2.2 Pediatric Vaccines Revenue Share by Manufacturers (2014-2019)
3.3 Pediatric Vaccines Price by Manufacturers
3.4 Pediatric Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Pediatric Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pediatric Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Pediatric Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Pediatric Vaccines Sales by Product
4.2 Global Pediatric Vaccines Revenue by Product
4.3 Pediatric Vaccines Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Pediatric Vaccines Breakdown Data by End User
6 North America
6.1 North America Pediatric Vaccines by Countries
6.1.1 North America Pediatric Vaccines Sales by Countries
6.1.2 North America Pediatric Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Pediatric Vaccines by Product
6.3 North America Pediatric Vaccines by End User
7 Europe
7.1 Europe Pediatric Vaccines by Countries
7.1.1 Europe Pediatric Vaccines Sales by Countries
7.1.2 Europe Pediatric Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pediatric Vaccines by Product
7.3 Europe Pediatric Vaccines by End User
8 Asia Pacific
8.1 Asia Pacific Pediatric Vaccines by Countries
8.1.1 Asia Pacific Pediatric Vaccines Sales by Countries
8.1.2 Asia Pacific Pediatric Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Pediatric Vaccines by Product
8.3 Asia Pacific Pediatric Vaccines by End User
9 Central & South America
9.1 Central & South America Pediatric Vaccines by Countries
9.1.1 Central & South America Pediatric Vaccines Sales by Countries
9.1.2 Central & South America Pediatric Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Pediatric Vaccines by Product
9.3 Central & South America Pediatric Vaccines by End User
10 Middle East and Africa
10.1 Middle East and Africa Pediatric Vaccines by Countries
10.1.1 Middle East and Africa Pediatric Vaccines Sales by Countries
10.1.2 Middle East and Africa Pediatric Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Pediatric Vaccines by Product
10.3 Middle East and Africa Pediatric Vaccines by End User
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 Company Business Overview
11.1.3 GlaxoSmithKline Pediatric Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.1.4 GlaxoSmithKline Pediatric Vaccines Products Offered
11.1.5 GlaxoSmithKline Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Company Business Overview
11.2.3 Merck Pediatric Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Merck Pediatric Vaccines Products Offered
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Company Business Overview
11.3.3 Pfizer Pediatric Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Pfizer Pediatric Vaccines Products Offered
11.3.5 Pfizer Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Company Business Overview
11.4.3 Sanofi Pediatric Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Sanofi Pediatric Vaccines Products Offered
11.4.5 Sanofi Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 Company Business Overview
11.5.3 AstraZeneca Pediatric Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.5.4 AstraZeneca Pediatric Vaccines Products Offered
11.5.5 AstraZeneca Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Company Business Overview
11.6.3 Novartis Pediatric Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Novartis Pediatric Vaccines Products Offered
11.6.5 Novartis Recent Development
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Details
11.7.2 Company Business Overview
11.7.3 Takeda Pharmaceutical Pediatric Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Takeda Pharmaceutical Pediatric Vaccines Products Offered
11.7.5 Takeda Pharmaceutical Recent Development
11.8 Bavarian Nordic
11.8.1 Bavarian Nordic Company Details
11.8.2 Company Business Overview
11.8.3 Bavarian Nordic Pediatric Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Bavarian Nordic Pediatric Vaccines Products Offered
11.8.5 Bavarian Nordic Recent Development
11.9 Baxter
11.9.1 Baxter Company Details
11.9.2 Company Business Overview
11.9.3 Baxter Pediatric Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Baxter Pediatric Vaccines Products Offered
11.9.5 Baxter Recent Development
11.10 LG Life Sciences
11.10.1 LG Life Sciences Company Details
11.10.2 Company Business Overview
11.10.3 LG Life Sciences Pediatric Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.10.4 LG Life Sciences Pediatric Vaccines Products Offered
11.10.5 LG Life Sciences Recent Development
11.11 Lupin
11.12 S K Chemicals
11.13 Mitsubishi Tanabe Pharma
11.14 Janssen
11.15 Shenzhen Kangtai Biological Products
11.16 Sinovac Biotech
11.17 Bharat Biotech
11.18 Crucell
11.19 Dynavax
11.20 Serum Institute of India
12 Future Forecast
12.1 Pediatric Vaccines Market Forecast by Regions
12.1.1 Global Pediatric Vaccines Sales Forecast by Regions 2020-2027
12.1.2 Global Pediatric Vaccines Revenue Forecast by Regions 2020-2027
12.2 Pediatric Vaccines Market Forecast by Product
12.2.1 Global Pediatric Vaccines Sales Forecast by Product 2020-2027
12.2.2 Global Pediatric Vaccines Revenue Forecast by Product 2020-2027
12.3 Pediatric Vaccines Market Forecast by End User
12.4 North America Pediatric Vaccines Forecast
12.5 Europe Pediatric Vaccines Forecast
12.6 Asia Pacific Pediatric Vaccines Forecast
12.7 Central & South America Pediatric Vaccines Forecast
12.8 Middle East and Africa Pediatric Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pediatric Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
